News | June 18, 2009

Study Looks at Impact of the Definition Utilized on Contrast-Induced Nephropathy in PCI

June 18, 2009 - Several definitions have been used to assess rates of contrast-induced nephropathy (CIN) in patients undergoing percutaneous coronary intervention (PCI), and a study this week in the American Journal of Cardiology (Vol. 103, Issues 12, pages 1,657-1,662, June 15, 2009), underlines the need to standardize these definitions.

The study examined if the definition influences observed rates of CIN. The study concluded CIN ranged in frequency from 3.3 to 10.5 percent depending on the definition used and was not associated with in-hospital mortality or substantial morbidity, such as dialysis. The wide variation in CIN and its lack of association with adverse outcomes underscore the need for a standardized, clinically relevant definition.

The Oxilan Registry was the first prospective analysis of the efficacy and safety of ioxilan (low-osmolar and low-viscosity contrast medium), including rates of CIN assessed by multiple definitions, in PCI. From July 2006 to June 2007, consecutive patients undergoing PCI using ioxilan were enrolled. Serum creatinine (SCr) and estimated glomerular filtration rate (eGFR) were assessed at baseline and three to five days after PCI. CIN was defined as SCr increase ?0.5 mg/dl, eGFR decrease ?25 percent, SCr increase ?25 percent or the composite.

Of 400 patients (age 62 ± 11 years), 19 percent were women, 37 percent were diabetic, 22 percent were anemic and 8 percent had a history of congestive heart failure. Baseline SCr was 1.12 ± 0.3 mg/dl, and 24 percent had an eGFR

Hospitalization was prolonged in 3.4 percent of patients with CIN and none required dialysis. There were no deaths or severe allergic reactions. Non–ST-elevation myocardial infarction and repeat revascularization each occurred in 0.8 percent.

For more information: www.ajconline.org

Related Content

Houston Methodist Hospital Enters Multi-Year Technology and Research Agreement With Siemens Healthineers
News | Cardiac Imaging| August 17, 2017
Houston Methodist Hospital and Siemens Healthineers have entered into a multi-year agreement to bring cutting-edge...
Siemens Healthineers Announces First U.S. Install of Artis Pheno Angiography System
News | Angiography| July 05, 2017
Michigan Medicine recently became the first healthcare institution in the United States to install the Artis pheno, the...
Sponsored Content | Videos | Angiography| June 22, 2017
Shimadzu Medical Systems highlighted new features of its Trinias Interventional X-ray line at the America College of
Sponsored Content | Videos | Angiography| May 03, 2017
Tom Kloetzly, sales and marketing VP for Shimadzu Medical Systems USA, explains the evolution of Shimadzu Corporation...
New Hampshire Hospital Expands Vascular Care with Toshiba Medical's Infinix-I Sky +
News | Angiography| April 27, 2017
Wentworth-Douglass Hospital in Dover, N.H., installed Toshiba Medical’s Infinix-i Sky + angiography system in its...
Louisiana Medical Center Installs First U.S. Toshiba Medical Infinix-i Sky +
News | Angiography| April 18, 2017
April 18, 2017 — Patients at Terrebonne General Medical Center (TGMC) in Houma, La., now have access to safe, high-qu
Sponsored Content | Videos | ACC| April 03, 2017
DAIC Editor Dave Fornell takes a tour of some of the interesting new technologies from the vendor booths on the expo
tryton side branch stent, dedicated coronary side branch stent

The FDA approval of the Tryton Side Branch Stent was the biggest technology news from March. It is deployed in the side branch artery using a standard single wire balloon-expandable stent delivery system. A conventional drug eluting stent is then placed in the main vessel.

Feature | April 03, 2017 | Dave Fornell
April 3, 2017 — Here is the list of the top 25 most popular pieces of content on the Diagnostic and Interventional Ca
Sponsored Content | Videos | Cath Lab| March 28, 2017
MDBuyline analyst Tom Watson shares some of the most important trends in cardiac technology he saw at the 2017 Americ
Philips, cardiology solutions, ACC.17, Azurion angiography system, iFR outcomes results, IntelliSpace Cardiovascular
News | Cardiac Imaging| March 24, 2017
At the 2017 American College of Cardiology's Annual Scientific Session & Expo (ACC.17), Philips showcased a broad...
Overlay Init